Clinical study services

Clinical study services
Colin Kerr
Colin Kerr
Published: Friday, November 1, 2019
Medeuronet, a medical device consulting firm focused on European market entry, has acquired the clinical study business assets from IROC Science in a private transaction. IROC Science (Zug, Switzerland) will continue to operate, focusing on developing ophthalmology products, collaborating with medeuronet until companies are ready to go to market. “After collaborating on ophthalmology projects over the past five years, this acquisition of IROC Science’s clinical business makes sense given medeuronet’s growing focus on clinical study services in ophthalmology,” said Kristine Morrill, medeuronet co-founder and lead on clinical studies and medical communications services. Prof Dr Michael Mrochen, founder and CEO of IROC Science said: “We are looking forward to working together to transition our clients over to the medeuronet team given its strong ability to successfully design, set-up and manage clinical studies in ophthalmology ranging from first-in-human to post-market clinical follow-up studies.” With the implementation of the new Medical Device Regulation (MDR) in just under a year, medeuronet is increasingly focused on assisting its clients in anticipating the new clinical data requirements that will be necessary to obtain and maintain CE marking. “There continues to be a great deal of misinformation and uncertainty about the new clinical requirements under MDR” said Ms Morrill. “We are helping our clients chart a practical path through this uncertainty, without significant increases in expenses. We remain positive about the benefits of European market entry and commercialisation and firmly believe that a ‘Europe first’ approach is the right one,” she said. https://www.medeuronet.com/
Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...